Morgan Stanley Downgrades Imperial Brands Target Price

Business by 2FIRSTS.ai
Nov.24.2023
Morgan Stanley Downgrades Imperial Brands Target Price
JP Morgan has lowered its price target for Imperial Brands (LON:IMB) from $29.40 to $28.15, maintaining a hold rating.

According to a report by MarketBeat, JP Morgan has lowered its price target for Imperial Brands (LON:IMB) from $29.40 to $28.15 in a report released on Monday. The company currently has a buy rating on the stock.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

A former Singapore Health and Science Agency (HSSA) authorized enforcement officer has been charged with leaking e-cigarette enforcement intelligence in a bribery case
A former Singapore Health and Science Agency (HSSA) authorized enforcement officer has been charged with leaking e-cigarette enforcement intelligence in a bribery case
A former e-cigarette enforcement chief in Singapore has been charged with accepting a S$8,000 (US$6,200) bribe after repeatedly providing intelligence to a man involved in an upcoming Health Sciences Authority (HSA) e-cigarette crackdown in 2024.
Sep.05 by 2FIRSTS.ai
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
At the Barclays Global Consumer Staples Conference, the CEO of Imperial Brands outlined the company’s 2025–2030 strategy and direction for its Next-Generation Products (NGP). He said the NGP business has been “reset,” delivering double-digit growth over the past two years, with the aim of sustaining this pace for the next five years. In response to disposable-vape bans in the UK and France, the company has completed a pivot to rechargeable pod systems, doubling its UK market share and surpassing
Sep.12 by 2FIRSTS.ai
Largest E-Cigarette Seizure in U.S. History: Over 600,000 Products Confiscated from Midwest Goods Warehouse; Company Denies Violations, Calls FDA “Unfair”
Largest E-Cigarette Seizure in U.S. History: Over 600,000 Products Confiscated from Midwest Goods Warehouse; Company Denies Violations, Calls FDA “Unfair”
The U.S. Department of Justice, together with the FDA and the U.S. Marshals Service, raided the warehouse of e-cigarette distributor Midwest Goods in Bensenville, Illinois, seizing more than 600,000 unauthorized e-cigarette products. Midwest Goods denied any violations, stating that the products had been submitted for premarket applications but remained unreviewed by the FDA for an extended period, and criticized the regulations as unfair to small and medium-sized businesses.
Sep.11 by 2FIRSTS.ai
Dutch survey: E-cigarettes containing synthetic cannabinoids are rampant in schools, endangering the health of minors
Dutch survey: E-cigarettes containing synthetic cannabinoids are rampant in schools, endangering the health of minors
An investigation by Dutch program Zembla found THC e-cigarettes with synthetic cannabinoids spreading quickly among schoolchildren. Lab tests confirmed the products are high-risk and potent, having caused students to vomit, faint, or be hospitalized. Addiction clinics report rising cases, and health officials warn educators of serious health and addiction risks.
Sep.12 by 2FIRSTS.ai
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.
Oct.23 by 2FIRSTS.ai
France bans oral nicotine products; BAT and Philip Morris slam “counterproductive” move, health groups applaud
France bans oral nicotine products; BAT and Philip Morris slam “counterproductive” move, health groups applaud
France has banned producing, importing, distributing, and consuming oral nicotine products (e.g., nicotine pouches, gum) without parliamentary debate or multi-stakeholder consultation. This has sparked strong opposition from firms like British American Tobacco France and Philip Morris France, which argue it contradicts EU discussions, deprives smokers of reduced-harm alternatives, and lacks scientific basis. However, anti-smoking group Alliance Contre le Tabac hails it as a "victory" for public
Sep.08